Publication | Open Access

Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model

Tumor BiologyBreast OncologyOncologyMedicineApoptosisRe-engineered P53 ActivatesCell DeathBreast CancerTumor SuppressorPrimary Tumor RegressionRadiation OncologyCancer BiologyCell BiologyCancer Research